|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.30 USD | +2.99% |
|
+4.92% | +2.59% |
Chart calendar AbbVie Inc.
Upcoming events on AbbVie Inc.
| 23/04/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 23/07/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 22/10/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 02/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on AbbVie Inc.
| 04/02/2026 | Q4 2025 Earnings Call |
| 04/02/2026 | Q4 2025 Earnings Release |
| 30/01/2026 | International Master Course on Aging Science World Congress |
| 30/01/2026 | International Master Course on Aging Science World Congress |
| 28/01/2026 | International Master Course on Aging Science World Congress - Frank Lin |
| 28/01/2026 | International Master Course on Aging Science World Congress - Andre Braz |
| 28/01/2026 | International Master Course on Aging Science World Congress - Koenraad De Boulle |
| 28/01/2026 | International Master Course on Aging Science World Congress - Charles Cheng |
| 28/01/2026 | International Master Course on Aging Science World Congress - Terrence Keaney |
| 28/01/2026 | International Master Course on Aging Science World Congress - Marion Moers Carpi |
| 28/01/2026 | International Master Course on Aging Science World Congress - Deirdre Hooper |
| 28/01/2026 | International Master Course on Aging Science World Congress - Françoise Boismal |
| 28/01/2026 | International Master Course on Aging Science World Congress - Corey Maas |
| 15/01/2026 | |
| 14/01/2026 | J.P. Morgan Healthcare Conference |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - 7543 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - 7534 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - 2683 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - 7495 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - 2333 |
Past dividends on AbbVie Inc.
| 15/01/2026 | Quarterly 1.73 USD |
| 14/10/2025 | Quarterly 1.64 USD |
| 14/07/2025 | Quarterly 1.64 USD |
| 14/04/2025 | Quarterly 1.64 USD |
| 14/01/2025 | Quarterly 1.64 USD |
| 14/10/2024 | Quarterly 1.55 USD |
| 14/07/2024 | Quarterly 1.55 USD |
| 11/04/2024 | Quarterly 1.55 USD |
| 11/01/2024 | Quarterly 1.55 USD |
| 11/10/2023 | Quarterly 1.48 USD |
| 12/07/2023 | Quarterly 1.48 USD |
| 12/04/2023 | Quarterly 1.48 USD |
| 11/01/2023 | Quarterly 1.48 USD |
| 12/10/2022 | Quarterly 1.41 USD |
| 13/07/2022 | Quarterly 1.41 USD |
| 12/04/2022 | Quarterly 1.41 USD |
| 12/01/2022 | Quarterly 1.41 USD |
| 13/10/2021 | Quarterly 1.3 USD |
| 13/07/2021 | Quarterly 1.3 USD |
| 13/04/2021 | Quarterly 1.3 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 58 054 58 284 -0.4% | 54 318 54 047 0.5% | 56 334 56 043 0.52% | 61 160 60 957 0.33% | 67 109 | 72 331 |
|
EBITDA Million USD | Released Forecast Spread | 30 961 31 181 -0.7% | 25 545 25 858 -1.21% | 24 104 23 980 0.52% | 0,00 24 611 - | 33 442 | 36 651 |
|
EBIT Million USD | Released Forecast Spread | 30 183 30 154 0.1% | 24 793 24 926 -0.53% | 23 340 23 323 0.07% | 23 721 23 906 -0.77% | 32 640 | 35 940 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13 477 16 796 -19.76% | 6 250 8 933 -30.04% | 3 716 10 308 -63.95% | 6 597 11 951 -44.8% | 22 096 | 24 421 |
|
Net income Million USD | Released Forecast Spread | 11 836 14 494 -18.34% | 4 863 8 288 -41.32% | 4 278 3 826 11.8% | 4 226 7 425 -43.08% | 17 162 | 20 233 |
|
EPS USD | Released Forecast Spread | 6,63 8,28 -19.89% | 2,72 5,30 -48.69% | 2,39 2,65 -9.64% | 2,36 3,58 -34.1% | 9,83 | 11,6 |
| Announcement Date | 09/02/23 | 02/02/24 | 31/01/25 | 04/02/26 |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 310 11 936 3.14% | 14 462 14 027 3.1% | 14 460 14 277 1.28% | 15 102 14 827 1.86% | 13 343 12 921 3.27% | 15 423 15 030 2.61% | 15 776 15 586 1.22% | 16 618 16 415 1.24% | 14 730 | 16 815 | 17 393 | 18 127 | 15 763 | 17 740 | 18 233 |
|
EBITDA Million USD | Released Forecast Spread | 5 378 5 444 -1.21% | 6 342 6 781 -6.47% | 6 937 6 847 1.31% | 5 447 5 447 0% | 5 829 5 958 -2.16% | 7 019 6 755 3.91% | 5 073 4 864 4.29% | 6 434 | 6 942 | 8 722 | 8 888 | 8 613 | |||
|
EBIT Million USD | Released Forecast Spread | 5 195 5 158 0.71% | 6 158 6 229 -1.14% | 6 746 6 639 1.61% | 5 241 5 246 -0.09% | 5 648 5 499 2.7% | 6 833 6 615 3.3% | 4 881 5 094 -4.18% | 6 359 6 572 -3.24% | 6 784 | 8 383 | 8 574 | 8 742 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 755 2 367 -25.86% | 2 146 3 226 -33.48% | 2 084 3 081 -32.36% | -2 269 3 000 -175.63% | 1 661 2 464 -32.59% | 1 554 3 517 -55.81% | 714 4 173 -82.89% | 2 668 4 223 -36.82% | 3 904 | 5 986 | 5 285 | 5 838 | |||
|
Net income Million USD | Released Forecast Spread | 1 369 1 220 12.17% | 1 370 1 912 -28.35% | 1 561 2 093 -25.42% | -22,0 -869 97.47% | 1 286 1 778 -27.69% | 938 1 891 -50.41% | 186 -1 149 116.19% | 1 816 5 088 -64.31% | 2 745 | 4 296 | 4 191 | 4 222 | |||
|
EPS USD | Released Forecast Spread | 0,77 0,66 16.08% | 0,77 1,49 -48.21% | 0,88 1,44 -38.72% | -0,02 -0,50 95.96% | 0,72 0,29 145.77% | 0,52 1,17 -55.61% | 0,10 -1,19 108.4% | 1,02 2,87 -64.51% | 1,55 | 2,35 | 2,30 | 2,38 | |||
| Announcement Date | 26/04/24 | 25/07/24 | 30/10/24 | 31/01/25 | 25/04/25 | 31/07/25 | 31/10/25 | 04/02/26 | - | - | - | - | - | - | - |
| 17/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 17/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for AbbVie Inc.
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2026 Earnings Release | |
| Today | Q3 2025 Earnings Release | |
| Today | Q3 2025 Earnings Release | |
| Today | Q4 2025 Earnings Release | |
| 12/02/2026 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
- Calendar AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















